Mechanistically, Jpx acts as a competing endogenous RNA (ceRNA) to regulate Nfatc3 (Nuclear factor of activated T cells 3) expression by binding miR-145-5p, subsequently promoting cardiac hypertrophy. The gene discussed is NFATC3; the disease is cardiac hypertrophy.